Ngā hua rapu - Sajla Singh
- E whakaatu ana i te 1 - 2 hua o te 2
-
1
New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment mā Laurence C. Cheung, Jennifer Tickner, Anastasia Hughes, Patrycja Skut, Meegan Howlett, Bree Foley, Joyce Oommen, Julia E. Wells, Bo He, Sajla Singh, Grace-Alyssa Chua, Jette Ford, Charles G. Mullighan, Rishi S. Kotecha, Ursula R. Kees
I whakaputaina 2018Artigo -
2
Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy mā Laurence C. Cheung, Carlos Aya‐Bonilla, Mark N. Cruickshank, Sung Kai Chiu, Vincent Kuek, Denise Anderson, Grace-Alyssa Chua, Sajla Singh, Joyce Oommen, Emanuela Ferrari, Anastasia Hughes, Jette Ford, Elena Kunold, Maria C. Hesselman, Frederik Post, Kelly E. Faulk, Erin H. Breese, Erin Guest, Patrick A. Brown, Mignon L. Loh, Richard B. Lock, Ursula R. Kees, Rozbeh Jafari, Sébastien Malinge, Rishi S. Kotecha
I whakaputaina 2022Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Cancer research
Immunology
Leukemia
Medicine
Activator (genetics)
Azacitidine
Bone marrow
Bone resorption
Cell biology
Chronic lymphocytic leukemia
DNA methylation
Decitabine
Gene
Gene expression
Genetics
Haematopoiesis
Hypomethylating agent
In vivo
Internal medicine
Methylation
Methyltransferase
Oncology
Osteoclast
Pharmacology
RANKL
Receptor
Stem cell
Venetoclax